Achievement Follows Healthfirst’s #1 Quality Rating Among New York State Medicaid and Essential Plans Healthfirst, a leading not-for-profit health plan serving more than two million...
Launch of new healthcare plan for dual-eligible members of Medi-Cal and Medicare Enrollment begins October 15 This week CenCal Health announced the launch of CenCal CareConnect, a new...
Aetna®, a CVS Health® company (NYSE: CVS), announced today that over 81 percent of its Medicare Advantage (MA) members are in 2026 Medicare Advantage Prescription Drug...
Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; “Renalys”) announced today that it has completed data collection for the primary endpoint in the Phase III clinical trial...
Kiel Laboratories, a leading strategic consulting and pharmaceutical services provider, announced the successful approval of its 16th New Drug Application (NDA) through the U.S. Food...
Millennium Physician Group, one of the largest physician-led healthcare groups in Florida, and IMA Medical Group, one of the largest Central Florida-based provider groups, announced...
Acquisition Expands National Patient Base and Strengthens Aptiva’s Leadership in Continuous Glucose Monitoring (CGM) Distribution Aptiva Medical, a Greenleaf Ventures portfolio company and one of...
Kronos, once valued at $3.5B, Had Two Phase 2 Stage Assets Ignota Labs, the AI drug turnaround company, has announced its acquisition of Kronos’s clinical...
Former Oracle leader joins to advance launch intelligence innovation Within3, the leading Launch Intelligence™ platform for life science, today announced the appointment of Ian McKinnon,...
With more than $45 million raised – including $4 million last year, 36,000 Totes for Hope delivered, 30 Breast Cancer Research Foundation grants funded, and more than $2 million generated for...
FILSPARI® (sparsentan) suggested for IgA Nephropathy patients who are at risk of progressive kidney function loss CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the...
Kayothera, Inc. (“Kayothera”), a preclinical therapeutics company developing first-in-class, small molecule inhibitors of the retinoid nuclear receptor pathway, today announces that it has selected KAYO-1732...
Trinity Capital Inc. (Nasdaq: TRIN) (the “Company”), a leading alternative asset manager, today announced the commitment of $45 million in growth capital to Rapid Micro Biosystems (Nasdaq: RPID) (“Rapid Micro”),...
Aetna®, a CVS Health® company (NYSE: CVS), today announced it will scale the Aetna Clinical Collaboration (ACC) program to ten hospitals by year-end, with implementations underway with AdventHealth...
Findings published in Advance Sciences reveal a novel molecular reaction that slows down sugar metabolism, reducing inflammatory cell death Researchers are closing in on new ways to...